SAGRES DISCOVERY has a total of 23 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SAGRES DISCOVERY INC, NAT BIO FOUNDER BIOTECHNOLOGY CO LTD and MORRIS DAVID W.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Analysing materials | |
#5 | Medical preparations | |
#6 | Sugars | |
#7 | Unspecified technologies | |
#8 | Unspecified technologies | |
#9 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Morris David W | 22 |
#2 | Engelhard Eric K | 5 |
#3 | Malandro Marc S | 4 |
#4 | Booher Robert | 1 |
#5 | Fanidi Abdallah | 1 |
#6 | Tse Christin | 1 |
#7 | Yu Guoying | 1 |
#8 | Xu Xie | 1 |
#9 | Rowe Michael | 1 |
#10 | Moler Edward | 1 |
Publication | Filing date | Title |
---|---|---|
CA2604884A1 | Ddr2 in cancer diagnosis, detection and treatment | |
WO03080853A1 | Novel compositions and methods in cancer associated with altered expression of tbx21 | |
CA2470844A1 | Novel compositions and methods for cancer | |
AU2002337943A1 | Novel compositions and methods for cancer | |
WO03008583A2 | Novel compositions and methods for cancer |